Several leading firms worldwide focus on the manufacture of complex medicinal APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Mesylate. These molecules present significant difficulties in process building due to their chemical sophistication. The producers of these APIs often employ specialized processes and adhere to strict regulatory gu